FDA OKs Long-Acting Risperidone; TMS for Anxious Depression; CBT Bests Pharma
(MedPage Today) -- The FDA approved the biweekly long-acting injectable (LAI) risperidone (Rykindo) for the treatment of schizophrenia and bipolar I disorder, Luye Pharma Group announced.
A phase IIa study showed a significantly greater improvement... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 18, 2023 Category: Psychiatry Source Type: news
FDA Approves Rykindo (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Bipolar 1 Disorder
PRINCETON, N.J., Jan. 15, 2023 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 15, 2023 Category: Drugs & Pharmacology Source Type: news
Eating Disorder Spike; $1M Fraud at Psych Clinic? Risperidone LAI Heads Back to FDA
(MedPage Today) -- After the start of the COVID-19 pandemic, there was a 7.2% increase in eating disorder-related inpatient and outpatient admissions each month among adolescents and young adults, lasting through April 2021. (JAMA Pediatrics)... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 9, 2022 Category: Psychiatry Source Type: news
Risk assessment of accidental falls in patients taking trazodone, quetiapine, or risperidone for insomnia: a single-center, case-control study - Shimizu Y, Taga M, Takahashi Y, Yamamoto Y, Masauji T.
In this study, we evaluated the risk of falls with trazodone, risperidone, and quetiapine, which are recommended for use at Kanaz... (Source: SafetyLit)
Source: SafetyLit - November 4, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Antipsychotic Tied to Weight Gain, Higher Cholesterol Antipsychotic Tied to Weight Gain, Higher Cholesterol
The antipsychotic risperidone is associated with small dose-related increases in weight and blood cholesterol levels over time, a large new study suggests.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 2, 2022 Category: Primary Care Tags: Psychiatry News Source Type: news
FDA Rejects Schizophrenia Tx; ADHD & Mental Health; Eating Disorder Treatment Scarce
(MedPage Today) -- The FDA hit Teva Pharmaceuticals and MedinCell with a complete response letter in regard to their new drug application for the schizophrenia treatment TV-46000/mdc-IRM (risperidone extended-release injectable suspension for subcutaneous... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 20, 2022 Category: Psychiatry Source Type: news
Novel Long-Acting Injection Cuts Schizophrenia Relapse Novel Long-Acting Injection Cuts Schizophrenia Relapse
A novel risperidone formulation cuts relapse risk in schizophrenia, new research suggests; but experts wonder: will it help improve the field ' s"deplorably low" use of long-acting antipsychotics?Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - April 12, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news
COVID-19 May Be Linked to Spontaneous Psychosis. Researchers Are Trying to Figure Out Why
In May 2020, a 33-year-old mother of three in North Carolina started experiencing symptoms of COVID-19. Four days later, a different set of symptoms set in. She stopped sleeping well and started having paranoid delusions that people were tracking her through her cell phone—culminating in a frantic scene at a fast-food restaurant, in which she tried to pass her children through the drive-through window, where they’d be safe from the phones and other dangers.
A restaurant employee called 911, and emergency medical services workers arrived, gathered up the family, and hurried to the nearby emergency department of...
Source: TIME: Health - March 4, 2022 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Janssen Announces U.S. FDA Approval of INVEGA HAFYERA ™(6-month paliperidone palmitate), First and Only Twice-Yearly Treatment for Adults with Schizophrenia
TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic INVEGA HAFYERA™ (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the treatment of schizophrenia in adults. Before transitioning to INVEGA HAFYERA™, patients must be adequately treated with INVEGA SUSTENNA® (1-month paliperidone palmitate) for at least four months, or INVEGA TRINZA® (3-month paliperidone palmitate) for at least one 3-month injection cycle.1 The FDA approval of INVEGA ...
Source: Johnson and Johnson - September 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon
A novel, ultra-long-acting formulation of risperidone allowed once-weekly dosing, rapidly achieved therapeutic levels, and was safe and effective, results of a phase 2 trial show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 3, 2021 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Star-shaped brain cells may be linked to stuttering
(University of California - Riverside) Astrocytes -- star-shaped cells in the brain that are actively involved in brain function -- may play an important role in stuttering, a study led by a University of California, Riverside, expert on stuttering has found. The study also suggests that treatment with the medication risperidone leads to increased activity of the striatum in persons who stutter. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2021 Category: International Medicine & Public Health Source Type: news
Cariprazine Trumps Risperidone for Negative Schizophrenia Symptoms Cariprazine Trumps Risperidone for Negative Schizophrenia Symptoms
Cariprazine is more effective than risperidone for persistent negative symptoms in schizophrenia and appears to be effective in patients resistant to previous treatment with other antipsychotic agents.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 9, 2020 Category: Consumer Health News Tags: Psychiatry News Source Type: news
How to manage patients on long-acting injectable (LAI, or depot) antipsychotics during the COVID-19 pandemic, NIHR
This guidance includes information about LAI antipsychotic medications which are currently licensed in the UK (that is: Xeplion ® , Trevicta ® , Abilify Maintena ® , Risperdal Consta ® , Zypadhera ® ) (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news
First-in-Class Antipsychotic Linked to Lower Cardiometabolic Risk First-in-Class Antipsychotic Linked to Lower Cardiometabolic Risk
A recently approved first-in-class antipsychotic appears to have fewer adverse cardiometabolic effects compared with placebo or standard care with risperidone, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 3, 2020 Category: Neurology Tags: Psychiatry News Source Type: news
CHMP Backs Generic Paliperidone for Schizophrenia CHMP Backs Generic Paliperidone for Schizophrenia
Paliperidone Janssen-Cilag International, a generic of Xeplion, is for maintenance treatment of schizophrenia in adults stabilized with paliperidone or risperidone and select other cases.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 2, 2020 Category: Consumer Health News Tags: Psychiatry News Source Type: news
